Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;6 Suppl 1(Suppl 1):S78-98.
doi: 10.3978/j.issn.2072-1439.2013.12.07.

Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam

Affiliations
Review

Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam

Kosmas Tsakiridis et al. J Thorac Dis. 2014 Mar.

Abstract

The majority of patients survive after extracorporeal circulation without any clinically apparent deleterious effects. However, disturbances exist in various degrees sometimes, which indicate the harmful effects of cardiopulmonary bypass (CPB) in the body. Several factors during extracorporeal circulation either mechanical dependent (exposure of blood to non-biological area) or mechanical independent (surgical wounds, ischemia and reperfusion, alteration in body temperature, release of endotoxins) have been shown to trigger the inflammatory reaction of the body. The complement activation, the release of cytokines, the leukocyte activation and accumulation as well as the production of several "mediators" such as oxygen free radicals, metabolites of arachidonic acid, platelet activating factors (PAF), nitric acid, and endothelin. The investigation continues today on the three metabolites of lornoxicam (the hydroxylated metabolite and two other metabolites of unknown chemical composition) to search for potential new pharmacological properties and activities.

Keywords: Lung; cardiopulmonary bypass (CPB); inflammation; markers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Contemporary machine of extracorporeal circulation.
Figure 2
Figure 2
The chemical formula of Lornoxicam.

Similar articles

Cited by

  • Minimally invasive procedures.
    Baltayiannis N, Michail C, Lazaridis G, Anagnostopoulos D, Baka S, Mpoukovinas I, Karavasilis V, Lampaki S, Papaiwannou A, Karavergou A, Kioumis I, Pitsiou G, Katsikogiannis N, Tsakiridis K, Rapti A, Trakada G, Zissimopoulos A, Zarogoulidis K, Zarogoulidis P. Baltayiannis N, et al. Ann Transl Med. 2015 Mar;3(4):55. doi: 10.3978/j.issn.2305-5839.2015.03.24. Ann Transl Med. 2015. PMID: 25861610 Free PMC article. Review.
  • Pneumothorax as a complication of central venous catheter insertion.
    Tsotsolis N, Tsirgogianni K, Kioumis I, Pitsiou G, Baka S, Papaiwannou A, Karavergou A, Rapti A, Trakada G, Katsikogiannis N, Tsakiridis K, Karapantzos I, Karapantzou C, Barbetakis N, Zissimopoulos A, Kuhajda I, Andjelkovic D, Zarogoulidis K, Zarogoulidis P. Tsotsolis N, et al. Ann Transl Med. 2015 Mar;3(3):40. doi: 10.3978/j.issn.2305-5839.2015.02.11. Ann Transl Med. 2015. PMID: 25815301 Free PMC article.
  • Pneumothorax: observation.
    Li Z, Huang H, Li Q, Zarogoulidis K, Kougioumtzi I, Dryllis G, Kioumis I, Pitsiou G, Machairiotis N, Katsikogiannis N, Papaiwannou A, Madesis A, Diplaris K, Karaiskos T, Zaric B, Branislav P, Zarogoulidis P. Li Z, et al. J Thorac Dis. 2014 Oct;6(Suppl 4):S421-6. doi: 10.3978/j.issn.2072-1439.2014.08.32. J Thorac Dis. 2014. PMID: 25337398 Free PMC article. Review.
  • Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis.
    Helmy HS, El-Sahar AE, Sayed RH, Shamma RN, Salama AH, Elbaz EM. Helmy HS, et al. Int J Nanomedicine. 2017 Sep 22;12:7015-7023. doi: 10.2147/IJN.S147738. eCollection 2017. Int J Nanomedicine. 2017. PMID: 29026298 Free PMC article.
  • Unusual causes of pneumothorax.
    Ouellette DR, Parrish S, Browning RF, Turner JF Jr, Zarogoulidis K, Kougioumtzi I, Dryllis G, Kioumis I, Pitsiou G, Machairiotis N, Katsikogiannis N, Tsiouda T, Madesis A, Karaiskos T, Zarogoulidis P. Ouellette DR, et al. J Thorac Dis. 2014 Oct;6(Suppl 4):S392-403. doi: 10.3978/j.issn.2072-1439.2014.08.07. J Thorac Dis. 2014. PMID: 25337394 Free PMC article. Review.

References

    1. Gibbon JH., Jr Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954;37:171-85; passim. - PubMed
    1. Lillehei CW, Cohen M, Warden HE, et al. The results of direct vision closure of ventricular septal defects in eight patients by means of controlled cross circulation. Surg Gynecol Obstet 1955;101:446-66 - PubMed
    1. Dewall RA, Gott VL, Lillehei CW, et al. A simple, expendable, artificial oxygenator for open heart surgery. Surg Clin North Am 1956:1025-34 - PubMed
    1. Kirklin JW, Dushane JW, Patrick RT, et al. Intracardiac surgery with the aid of a mechanical pump-oxygenator system (gibbon type): report of eight cases. Proc Staff Meet Mayo Clin 1955;30:201-6 - PubMed
    1. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997;112:676-92 - PubMed